www.neurologiepropraxi.cz / Neurol. praxi. 2025;26(4):312-317 / NEUROLOGIE PRO PRAXI 317 Z POMEZÍ NEUROLOGIE Role střevní dysbiózy v patogenezi neurodegenerativních onemocnění ms and Microbiomes. 2022;8(1). doi:https://doi.org/10.1038/ s41522-022-00367-z. 14. Noor Eddin A, Alfuwais M, Noor Eddin R, et al. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives. Nutrients. 2024;16(5):590. doi:https://doi.org/10.3390/nu16050590. 15. Park SH, Lee JH, Kim JS, et al. Fecal microbiota transplantation can improve cognition in patients with cognitive decline and Clostridioides difficile infection. Aging. 2022;14(16):64496466. doi:https://doi.org/10.18632/aging.204230. 16. Qian Y, Yang X, Xu S, et al. Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease. Brain, Behavior, and Immunity. 2018;70:194-202. doi:https://doi.org/10.1016/j.bbi.2018.02.016. 17. Rojas-Valverde D, Bonilla DA, Luis Mario Gómez-Miranda, et al. Examining the Interaction between Exercise, Gut Microbiota, and Neurodegeneration: Future Research Directions. Biomedicines. 2023;11(8):2267-2267. doi:https://doi. org/10.3390/biomedicines11082267. 18. Rowin J, Xia Y, Jung B, Sun J. Gut inflammation and dysbiosis in human motor neuron disease. Physiological reports. 2017;5(18):e13443. doi:https://doi.org/10.14814/phy2.13443. 19. Syeda Elezeh Sabahat, Saqib M, Talib M, Shaikh TG, et al. Bile acid modulation by gut microbiota: A bridge to understanding cognitive health. Annals of Medicine and Surgery. 2024;86(9):5410-5415. doi:https://doi.org/10.1097/ ms9.0000000000002433. 20. Scheperjans F, Levo R, Bosch B, et al. Fecal Microbiota Transplantation for Treatment of Parkinson Disease. JAMA Neurology. 2024;81(9):925. doi:https://doi.org/10.1001/jamaneurol.2024.2305. 21. Toepfer C, Folwaczny A, Klauser, RLM. Gastrointestinal dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders. 2000;1(1):15-19. doi:https://doi.org/10.1080/146608299300079484. 22. Track NS. The gastrointestinal endocrine system. Can Med Assoc J. 1980;122(3):287-292. 23. Vineis P, Robinson O, Chadeau-Hyam M, et al. What is new in the exposome? Environment International. 2020;143:105887. doi:https://doi.org/10.1016/j.envint.2020.105887. 24. Yan J, Chen H, Zhang Y, et al. Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis. Gut Microbes. 2024;16(1). doi:https://doi. org/10.1080/19490976.2024.2353396. 25. Zhai CD, Zheng J, An BC, et al. Intestinal microbiota composition in patients with amyotrophic lateral sclerosis. Chinese Medical Journal. 2019;132(15):1815-1822. doi:https://doi. org/10.1097/cm9.0000000000000351. 26. Zhang H, Chen Y, Wang Z, et al. Implications of Gut Microbiota in Neurodegenerative Diseases. Frontiers in Immunology. 2022;13. doi:https://doi.org/10.3389/fimmu.2022.785644. 27. Zhang L, Zhuang Z, Zhang G, et al. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study. BMC Neurology. 2022;22(1). doi:https://doi.org/10.1186/s12883-021-02522-z. 28. Zhang R, Miller RG, Gascon R, et al. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). Journal of Neuroimmunology. 2009;206(1):121-124. doi:https://doi.org/10.1016/j.jneuroim.2008.09.017. 29. Zhang Y, Ogbu D, Garrett S, et al. Aberrant enteric neuromuscular system and dysbiosis in amyotrophic lateral sclerosis. Gut Microbes. 2021;13(1). doi:https://doi.org/10.1080/1 9490976.2021.1996848. 30. Zhao J, Bi W, Xiao S, et al. Neuroinflammation induced by lipopolysaccharide causes cognitive impairment in mice. Scientific Reports. 2019;9(1). doi:https://doi.org/10.1038/s41598019-42286-8. 31. Zhao Y, Cong L, Jaber V, Lukiw WJ. Microbiome-Derived Lipopolysaccharide Enriched in the Perinuclear Region of Alzheimer’s Disease Brain. Frontiers in Immunology. 2017;8. doi:https://doi.org/10.3389/fimmu.2017.01064. 32. Zhao Z, Chen J, Zhao D, et al. Microbial biomarker discovery in Parkinson’s disease through a network-based approach. npj Parkinson s Disease. 2024;10(1). doi:https://doi.org/10.1038/ s41531-024-00802-2. 33. Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Research. 2020;30(6):492-506. doi:https://doi.org/10.1038/s41422-0200332-7. 28. 29. 1. 2026 PLZEŇ 13. konference Neurologie pro praxi MÍSTO KONÁNÍ Parkhotel Congress Center Plzeň, U Borského parku 31, Plzeň www.visitplzen.eu
RkJQdWJsaXNoZXIy NDA4Mjc=